About The Oncology Institute of Hope and Innovation
"Founded in 2007, The Oncology Institute of Hope and Innovation is dedicated to excel in cancer prevention, diagnosis and education. As the largest private practice cancer center in California, The Oncology Institute continues to provide extensive services including state-of-the-art infusion centers, chemotherapy educational sessions, in-house support groups, dietary and nutritional counseling, in-house pharmacy, financial counseling, clinical trials, comprehensive lab testing, and end of life counseling."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Oncology Institute of Hope and Innovation
During the past decade, The Oncology Institute of Hope and Innovation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Oncology Institute of Hope and Innovation
According to Clinical.Site data, the most researched conditions in "The Oncology Institute of Hope and Innovation" are
"Cancer" (1 trials), "End of Life" (1 trials), "Follicular Lymphoma (FL)" (1 trials), "Marginal Zone Lymphoma" (1 trials) and "Non Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "The Oncology Institute of Hope and Innovation" in a lesser frequency.
Clinical Trials Intervention Types at The Oncology Institute of Hope and Innovation
Most popular intervention types in "The Oncology Institute of Hope and Innovation" are "Behavioral" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Program participants" (1 trials), "Usual Care" (1 trials) and "Zandelisib (ME-401)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Oncology Institute of Hope and Innovation
The vast majority of trials in "The Oncology Institute of Hope and Innovation" are
2 trials for "All" genders.
Clinical Trials Status at The Oncology Institute of Hope and Innovation
Currently, there are NaN active trials in "The Oncology Institute of Hope and Innovation".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in The Oncology Institute of Hope and Innovation,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Oncology Institute of Hope and Innovation, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".